NIDA Notes keeps you up to date on research advances in the causes, consequences, prevention, and treatment of drug abuse and addiction and HIV/AIDS.
Learn more about NIDA Notes
Reports on a new device that creates tiny painless punctures in the skin to allow medication to flow evenly from a skin patch into dermal capillaries and the bloodstream.
Announces the recipient of a 2009 award for innovation in research on drug addiction and alcoholism whose research focuses on the cellular changes that occur in response to chronic cocaine abuse.
Describes research providing evidence that chronic methamphetamine abuse is associated with increased microglial cell activity in the brain leading to neurodegeneration.
Discusses the work of researchers who have begun to harness the potential of computers to reinforce and expand upon the well-established benefits of recovery therapy delivered by a counselor.
Highlights the disproportionately high rate of Americans who have used cocaine at some time during their lives as compared with other nations surveyed.
Discusses the work of NIDA’s Division of Epidemiology, Services and Prevention Research, organized to track drug use and provide empirically based information for researchers and service providers.
Highlights activities held during Brain Awareness Week for students in Maryland, Virginia, and Washington, DC, to learn about brain anatomy and function.
Describes research on the effectiveness of a buprenorphine patch to alleviate opioid withdrawal symptoms of newly abstinent heroin abusers.
Highlights the need for research to assess and find solutions to a potential rise in substance abuse among service men and women, veterans, and their families.
Highlights data on the prevalence of people entering substance abuse treatment programs who also reported having at least one co-occurring mental health problem.
Why Do People Lose Control Over Their Cocaine Use?
Testing a Prospective Medication To Help People Avoid Relapse
Electronic Tools for Use in the Continuum of Care for Patients With Addiction
Researchers Speak: Dr. Thomas Kosten on Anti-Drug Vaccines